Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This modular Program will first confirm the safety and efficacy of Paromomycin IM Injection
when given to an expanded population in the outpatient setting in experienced VL centers and
subsequently evaluate the effectiveness of an expanded access model of providing Paromomycin
IM Injection to progressively more resource-constrained clinics in Bihar, India.